Human papillomavirus vaccination rates and state mandates for tetanus-containing vaccines.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 21195727.
- Also identified by DOI 10.1016/j.ypmed.2010.12.010 and PMC identifier 3062651.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We sought to examine nationally the association between school mandates for adolescent tetanus-containing vaccines (Td and/or Tdap) and adolescent female human papillomavirus (HPV) vaccination. Each state was categorized by whether a school mandate for adolescent Td and/or Tdap vaccines was enacted. Mean HPV vaccine series initiation levels among adolescent females were compared between each mandate category. Mean HPV vaccine series initiation levels were significantly lower in states without Td/Tdap vaccine mandates than in those with mandates (42.9% vs. 47.3%; p=0.004). School mandates for adolescent Td/Tdap vaccination may have a carry-over effect on HPV vaccination.
Medical subject headings
- Adolescent
- Female
- Humans
- Immunization Programs
- Immunization Programs/standards
- Immunization Programs/statistics & numerical data
- Mandatory Programs
- Mandatory Programs/standards
- Papillomavirus Vaccines
- Papillomavirus Vaccines/standards
- Papillomavirus Vaccines/therapeutic use
- Patient Acceptance of Health Care
- Patient Acceptance of Health Care/statistics & numerical data
- Schools
- Schools/standards
- State Government
- Tetanus Toxoid
- Tetanus Toxoid/standards
- Tetanus Toxoid/therapeutic use
- United States